| Ident. | Authors (with country if any) | Title |
|---|
| 002834 (2013) |
Daniel E. Furst [États-Unis] ; Edward Clark Keystone [Canada] ; Alexander K. So [États-Unis, Canada, Allemagne, Pays-Bas, Italie, Royaume-Uni, Autriche] ; Jürgen Braun [Allemagne] ; Ferry C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Italie] ; Fabrizio De Benedetti [Allemagne] ; Thomas Dörner [Allemagne] ; Paul Emery [Royaume-Uni] ; Roy Fleischmann [États-Unis] ; Allan Gibofsky [États-Unis] ; J R Kalden [Allemagne] ; Arthur Kavanaugh [États-Unis] ; Bruce Kirkham [Royaume-Uni] ; Philip Mease [États-Unis] ; A. Rubbert-Roth [Allemagne] ; Joachim Sieper [Allemagne] ; Nora G. Singer [États-Unis] ; Josef S. Smolen [Autriche] ; Piet L C M. Van Riel [Pays-Bas] ; Michael H. Weisman [États-Unis] ; Kevin L. Winthrop [États-Unis] | Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012 |
| 002835 (2013) |
Edith Villeneuve [Canada] ; Boulos Haraoui [Canada] | Uncoupling of disease activity and structural damage. Does it matter clinically? |
| 002836 (2013) |
Nienke Ter Haar [Pays-Bas] ; Helen Lachmann [Royaume-Uni] ; Seza Özen [Turquie] ; Pat Woo [Royaume-Uni] ; Yosef Uziel [Israël] ; Consuelo Modesto [Espagne] ; Isabelle Koné-Paut [France] ; Luca Cantarini [Italie] ; Antonella Insalaco [Italie] ; Bénédicte Neven [France] ; Michael Hofer [Suisse] ; Donato Rigante [Italie] ; Sulaiman Al-Mayouf [Arabie saoudite] ; Isabelle Touitou [France] ; Romina Gallizzi [Italie] ; Efimia Papadopoulou-Alataki [Grèce] ; Silvana Martino [Italie] ; Jasmin Kuemmerle-Deschner [Allemagne] ; Laura Obici [Italie] ; Nicolae Iagaru [Roumanie] ; Anna Simon [Pays-Bas] ; Susan Nielsen [Danemark] ; Alberto Martini [Italie] ; Nicolino Ruperto [Italie] ; Marco Gattorno [Italie] ; Joost Frenkel [Pays-Bas] | Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review |
| 002850 (2013) |
In-Ho Song [Allemagne] ; Frank Heldmann [Allemagne] ; Martin Rudwaleit [Allemagne] ; Joachim Listing [Allemagne] ; Heiner Appel [Allemagne] ; Iris Haug-Rost [Allemagne] ; Jürgen Braun [Allemagne] ; Joachim Sieper [Allemagne] | One-year follow-up of ankylosing spondylitis patients responding to rituximab treatment and re-treated in case of a flare |
| 002855 (2013) |
C. Malattia [Italie] ; A. Consolaro [Italie] ; S. Pederzoli [Italie] ; A. Madeo [Italie] ; A. Pistorio [Italie] ; M. Mazzoni [Italie] ; C. Mattiuz [Italie] ; Gm Magnano [Italie] ; S. Viola [Italie] ; A. Buoncompagni [Italie] ; E. Palmisani [Italie] ; R. Hasija [Italie] ; N. Ruperto [Italie] ; A. Ravelli [Italie] ; A. Martini [Italie] | MRI versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in juvenile idiopathic arthritis |
| 002864 (2013) |
Philip G. Conaghan [Royaume-Uni] ; Patrick Durez [Belgique] ; Rieke E. Alten [Allemagne] ; Gerd-Rüdiger Burmester [Allemagne] ; Paul P. Tak [Pays-Bas, Royaume-Uni] ; Lars Klareskog [Suède] ; Anca Irinel Catrina [Suède] ; Julie Dicarlo [États-Unis] ; Corine Gaillez [France] ; Manuela Le Bars [France] ; Xianhuang Zhou [États-Unis] ; Charles Peterfy [États-Unis] | Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trial |
| 002872 (2013) |
Daniel E. Furst [États-Unis] ; Roy Fleischman [États-Unis] ; Joachim Kalden [États-Unis] ; Arthur Kavanaugh [États-Unis] ; Joachim Sieper [États-Unis] ; Philip Mease [États-Unis] ; Josef Smolen [États-Unis] ; Ferrie Breedveld [États-Unis] | Documentation of off-label use of biologics in Rheumatoid Arthritis |
| 002874 (2013) |
Josef S. Smolen [Autriche] ; Monika M. Schoels [Autriche] ; Norihiro Nishimoto [Japon] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino [Espagne] ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho Murakami [Japon] ; Neil Betteridge [Royaume-Uni] ; Clifton O. Bingham [États-Unis] ; Vivian Bykerk [Suisse] ; Ernest H. Choy [Royaume-Uni] ; Bernard Combe [France] ; Maurizio Cutolo [Italie] ; Winfried Graninger [Autriche] ; Angel Lanas [Espagne] ; Emilio Martin-Mola [Espagne] ; Carlomaurizio Montecucco [Italie] ; Mikkel Ostergaard [Danemark] ; Karel Pavelka [République tchèque] ; Andrea Rubbert-Roth [Allemagne] ; Naveed Sattar [Royaume-Uni] ; Marieke Scholte-Voshaar [Suisse] ; Yoshiya Tanaka [Japon] ; Michael Trauner [Autriche] ; Gabriele Valentini [Italie] ; Kevin L. Winthrop [États-Unis] ; Maarten De Wit [Pays-Bas] ; Désirée Van Der Heijde [Pays-Bas] | Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions |
| 002878 (2013) |
Monika M. Schoels [Autriche] ; Désirée Van Der Heijde [Pays-Bas] ; Ferdinand C. Breedveld [Pays-Bas] ; Gerd R. Burmester [Allemagne] ; Maxime Dougados [France] ; Paul Emery [Royaume-Uni] ; Gianfranco Ferraccioli [Italie] ; Cem Gabay [Suisse] ; Allan Gibofsky [États-Unis] ; Juan Jesus Gomez-Reino ; Graeme Jones [Australie] ; Tore K. Kvien [Norvège] ; Miho M. Murikama [Japon] ; Norihiro Nishimoto [Japon] ; Josef S. Smolen [Autriche] | Blocking the effects of interleukin-6 in rheumatoid arthritis and other inflammatory rheumatic diseases: systematic literature review and meta-analysis informing a consensus statement |
| 002881 (2013) |
Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas] | Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY) |
| 002913 (2013) |
R. Bakker [Pays-Bas] ; A. V. Ede [Pays-Bas] ; F. Lamers-Karnebeek [Pays-Bas] ; I. Meek [Pays-Bas] ; T. Jansen [Pays-Bas] | THU0577 Protocol-Bvased Pharmacotherapy in Gout Delivered by Specialised Health Care Professional Under Supervision of a Rheumathologist is Similar but not Significantly Superior to Care as Usual |
| 002914 (2013) |
M. Pavic-Nikolic [Slovénie] | THU0576 Are Patients in Slovenia Empowered for Self-Administration of Biological Medicines? |
| 002915 (2013) |
M. Kaneko [Japon] ; S. Honjo [Japon] | THU0575 Long-Term QOL Evaluation with AIMS-2 in Patients with Rheumatoid Arthritis - Two-Year Evaluation in Patients Receiving Treatment with Biologicals |
| 002921 (2013) |
J. Anton ; I. Calvo ; A. Robles [Espagne] ; J. Yagüe ; J. Ar Stegui ; R. Viana [Espagne] ; L. Tseng [États-Unis] ; K. Abrams [États-Unis] | THU0490 Canakinumab Treatment of Patients with Hyper-IgD Syndrome: An Open-Label, Multicenter, Pilot Study |
| 002922 (2013) |
M. Hoepfner ; T. Witte ; N. Pursche ; F. Moosig [Allemagne] ; W. Gross [Allemagne] ; R. E. Schmidt ; N. T. Baerlecken | THU0489 Antibodies Binding to DRP-4 and Macropain Subunit C2 as a Potential Marker of AOSD |
| 002923 (2013) |
Y. Takakuwa ; S. Ooka ; H. Ito [Japon] ; T. Kiyokawa [Japon] ; H. Nakano ; M. Hiida [Japon] ; H. Yamada ; S. Ozaki | THU0488 Efficacy and Safety of Biologic Agents for the Treatment of Refractory Adult Still’s Disease |
| 002932 (2013) |
S. Sanchez [Espagne] ; S. Iniesta [Espagne] ; M. P. Lisbona [Espagne] ; A. Pàmies [Espagne] ; M. Almirall [Espagne] ; J. Maymo [Espagne] ; J. Carbonell [Espagne] | THU0461-HPR Global assessment of disease by the patient in the new ACR/EULAR remission criteria: Why do not fulfil the remission? |
| 002933 (2013) |
H. Lööf ; F. Saboonchi ; E. Welin Henriksson ; S. Lindblad ; U.-B. Johansson [Suède] | THU0460-HPR Psychometric testing of the body awareness questionnaire in an swedish sample of patients diagnosed with rheumatoid arthritis |
| 002934 (2013) |
A. A. Marques [Portugal] ; R. Ferreira [Portugal] ; T. Santiago [Portugal] | THU0459-HPR Anxiety and depression scores reduction after six-months of biology therapy |
| 002950 (2013) |
R. Goldbach-Mansky [États-Unis] ; C. Sibley [États-Unis] ; S. D. Felix [Suisse] ; C. Brewer [États-Unis] ; K. King [États-Unis] ; C. Zalewski [États-Unis] ; H. J. Kim [États-Unis] ; R. Bishop [États-Unis] ; A. Chakraborty [États-Unis] ; L. Colin [Suisse] ; A. Chioato [Suisse] | THU0402 Efficacy and safety of canakinumab in patients with NOMID/CINCA |
| 002951 (2013) |
P. Efthimiou ; O. Petryna [États-Unis] ; B. Mehta [États-Unis] ; A. Kontzias ; J. Cush [États-Unis] | THU0401 Successful use of canakinumab in adult-onset still’s disease refractory to short acting IL-1 inhibitors |
| 002952 (2013) |
N. Stein [Allemagne] ; M. Witt [Allemagne] ; M. Baeuerle [Allemagne] ; H. Schulze-Koops [Allemagne] ; M. Gruenke [Allemagne] | THU0400 Inhibition of IL-6 signalling: A novel therapeutic approach for familial mediterranean fever |
| 002953 (2013) |
M. Ozmen ; V. Kurtoglu [Turquie] ; G. Can ; E. F. Tarhan ; D. Soysal [Turquie] ; S. L. Aslan [Turquie] | THU0399 Is pernio a microvascular disease? |
| 002954 (2013) |
M. Yamamoto ; H. Takahashi ; Y. Naishiro ; T. Tabeya ; K. Ishigami ; Y. Shimizu ; H. Yajima ; M. Matsui ; C. Suzuki ; H. Yamamoto ; S. Honda ; T. Abe ; Y. Suzuki ; T. Himi ; K. Imai [Japon] ; Y. Shinomura | THU0398 Efficacy of rituximab and other immunosuppressants for IgG4-related disease |
| 002955 (2013) |
M. El Rakaawi ; N. Hammoumraoui ; S. Mellal ; F. Sadouki ; S. Lehtihet ; W. Kerri [Algérie] ; H. Djoudi | THU0397 Efficacy of pamidronate in children with osteogenesis imperfecta: An open prospective study |
| 002956 (2013) |
L. O. Damian ; I. Felea ; S.-P. Simon ; M. Lupse ; C. Bodolea [Roumanie] ; L. Ghib ; R. Mocanu ; S. Rednic | THU0394 Macrophage activation syndrome in adult onset still’s disease: A single center experience |
| 002959 (2013) |
I. Pérez-Martín ; R. Blanco ; N. Ortego ; V. Llorens-Bellés [Espagne] ; A. Adán [Espagne] ; A. Olivé ; W. A. Sifuentes Giraldo [Espagne] ; S. González [Espagne] ; C. Bejerano ; M. C. González-Vela ; M. A. González-L Pez ; H. Fernández-Llaca ; A. Oterino ; M. J. Sedano ; M. Agudo ; A. Corrales ; V. M. Martínez-Taboada ; M. A. G Nzalez-Gay | THU0391 Anti-TNF therapy in severe and refractory sarcoidosis: Multicenter study of 25 patients |
| 002960 (2013) |
I. Ben-Zvi ; T. Krichely-Vachdi ; O. Feld ; M. Lidar ; S. Kivity [Israël] ; A. Livneh | THU0390 Prolonged disease-free interval in familial mediterranean fever: A distinct subset with unique clinical, demographic and molecular characteristics |
| 002961 (2013) |
S. Ugurlu [Turquie] ; F. Mehmedali [Turquie] ; F. Nalci [Turquie] ; A. Gurbuz [Turquie] ; B. Canbay [Turquie] ; Y. Sengul [Turquie] ; G. Hatemi [Turquie] ; H. Ozdogan [Turquie] | THU0389 Erythema over the joint may help to distinguish familial mediterranean fever from other rheumatologic conditions |
| 002962 (2013) |
H. M. Al Attia [Émirats arabes unis] ; M. A. Ibrahim [Émirats arabes unis] | THU0388 Tocilizumab strongly suppresses the serum amyloid a level in refractory adult – onset still’s disease associated amyloidosis |
| 002966 (2013) |
H. J. Lachmann [Royaume-Uni] ; J. D. Gillmore [Royaume-Uni] ; A. D. Wechalekar [Royaume-Uni] ; S. D. Gibbs [Royaume-Uni] ; J. H. Pinney [Royaume-Uni] ; D. M. Rowczenio [Royaume-Uni] ; H. Trojer [Royaume-Uni] ; T. Lane [Royaume-Uni] ; C. P. Venner [Royaume-Uni] ; S. M. Banypersad [Royaume-Uni] ; J. A. Gilbertson [Royaume-Uni] ; F. T. Hunt [Royaume-Uni] ; D. Gopaul [Royaume-Uni] ; D. F. Hutt [Royaume-Uni] ; N. Wassef [Royaume-Uni] ; M. B. Pepys [Royaume-Uni] ; P. N. Hawkins [Royaume-Uni] | THU0379 A 20 year single centre experience of aa amyloidosis demonstrating changes in its epidemiology |
| 002967 (2013) |
M. Murakami [Japon] ; T. Matsutani [Japon] ; C. Aoki [Japon] ; H.-M. Lee [Japon] ; Y. Li [Japon] ; N. Nishimoto [Japon] | THU0378 Interleukin-6 blocking therapy by tocilizumab in patients with multicentric castleman’s disease results in a significant decrease in serum levels of IgG4 and IGE |
| 002968 (2013) |
H. D. De Koning [Pays-Bas] ; J. Schalkwijk [Pays-Bas] ; J. Van Der Ven-Jongekrijg ; M. Stoffels ; J. W. Van Der Meer ; A. Simon | THU0377 Efficacy, safety and pharmacokinetics of the anti-interleukin-1 beta antibody canakinumab in patients with schnitzler syndrome |
| 002969 (2013) |
L. Cantarini ; L. Obici ; G. Simonini [Italie] ; R. Cimaz [Italie] ; M. R. Bacarelli ; G. Merlini ; A. Vitale ; O. M. Lucherini ; M. G. Brizi ; M. Galeazzi ; A. Fioravanti | THU0376 Serum leptin, resistin, visfatin and adiponectin levels in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) |
| 002979 (2013) |
S. Vastert ; W. De Jager [Pays-Bas] ; B. J. Noordman [Pays-Bas] ; D. Holzinger [Allemagne] ; W. Kuis ; B. Prakken ; N. Wulffraat | THU0333 Effectiveness and long-term follow up of recombinant IL-1RA as first line therapy in newly onset juvenile idiopathic arthritis |
| 002980 (2013) |
R. Carrasco [Royaume-Uni] ; L. R. Wedderburn [Royaume-Uni] ; H. E. Foster ; E. Baildam ; J. Gardner-Medwin [Royaume-Uni] ; A. Chieng [Royaume-Uni] ; J. Davidson [Royaume-Uni] ; W. Thomson [Royaume-Uni] ; K. Hyrich [Royaume-Uni] | THU0332 Predictors of poor growth in children with early juvenile idiopathic arthritis: Results from the childhood arthritis prospective study (CAPS) |
| 002986 (2013) |
G. Horneff ; K. Minden [Allemagne] ; I. Foeldvari [Allemagne] | THU0310 Performance of the juvenile arthritis disease activity score JADAS compared to the acr pediatric measures of response in 1470 juvenile idiopathic arthritis patients |
| 002991 (2013) |
T. Hallinen [Finlande] ; E. J. Soini [Finlande] ; A. Diamantopoulos [Royaume-Uni] ; F. Dejonckheere [Suisse] ; V. Vihervaara ; A. Hautala ; K. Aalto [Finlande] | THU0305 Cost-utility of tocilizumab in the treatment of systemic juvenile idiopathic arthritis in finland |
| 002992 (2013) |
E. Denisova [Russie] ; L. Katargina [Russie] ; A. Starikova [Russie] ; N. Lubimova [Russie] | THU0304 Efficacy of biologic therapies for pediatric rheumatic diseases associated uveitis |
| 002993 (2013) |
S. Valiyeva [Russie] ; E. Alexeeva [Russie] ; T. Bzarova [Russie] ; R. Denisova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie] | THU0303 The efficacy and safety of ibandronic acid for intravenous administration for treatment of severe systemic osteoporosis in patients with juvenile arthritis |
| 002994 (2013) |
E. Alexeeva [Russie] ; R. Denisova [Russie] ; S. Valiyeva [Russie] ; T. Bzarova [Russie] ; K. Isayeva [Russie] ; T. Sleptsova [Russie] ; E. Mitenko [Russie] | THU0302 Safety and efficacy of tocilizumab therapy in children with systemic onset of juvenile idiopathic arthritis |
| 002995 (2013) |
E. Olesinska ; J. Postepski ; J. Tabarkiewicz ; B. Wilczynska ; E. Tuszkiewicz-Misztal [Pologne] | THU0301 Neopterin (NPT) and soluble interleukin 2 receptor (SIL-2R) as useful markers of disease activity in juvenile idiopathic arthritis (JIA) |
| 002A00 (2013) |
K. Kume ; K. Amano ; S. Yamada ; T. Kanazawa ; H. Ohta ; K. Hatta [Japon] | THU0211 Combination of Intra-Articular Steroid Injection and Etanercept More Effective Than Etanercept in Rapid Radiographic Progression Patients with Rheumatoid Arthritis: A Randomized, Open Label, X Ray Reader Blinded Study |
| 002A06 (2013) |
S.-H. Park [États-Unis] ; I. Castrej N [États-Unis] ; J.-Y. Choe ; S.-K. Kim ; H.-J. Lee ; T. Pincus [États-Unis] | THU0166 Associations of Formal Education Level with Rheumatoid Arthritis (RA) Core Data Set Variables and Indices in Korean Patients |
| 002A07 (2013) |
I. Castrej N [États-Unis] ; M. Dougados [France] ; B. Combe [France] ; F. Guillemin [France] ; B. Fautrel [France] ; T. Pincus [États-Unis] | THU0165 Predictive Value of Different Remission Criteria for a Good Functional Status Outcome: Results from the Espoir Cohort |
| 002A08 (2013) |
I. Guseva ; N. Demidova ; N. Soroka [Russie] ; E. Panasyuk ; E. Luchikhina ; E. Fedorenko ; E. Alexandrova ; A. Novikov ; D. Trofimov [Russie] ; D. Karateev ; E. Nasonov | THU0164 Polymorphism of Cytotoxic T-Lymphocyte Antigen 4 +49A/G is Associated with Refractoriness to Non-Biological Dmards in Rheumatoid Arthritis Patients |
| 002A11 (2013) |
H. H. Nordal ; H. B. Hammer ; M. K. Fagerhol [Norvège] ; A. K. Halse [Norvège] ; R. Jonsson ; J. G. Brun [Norvège] | THU0158 The Inflammatory Marker S100A12 is Highly Associated with a Comprehensive 78-Joints Ultrasonographic Synovitis Score in Patients with Rheumatoid Arthritis Treated with Adalimumab |
| 002A12 (2013) |
H. B. Hammer [Norvège] ; T. K. Kvien [Norvège] | THU0157 Comprehensive Ultrasound Assessments are Closely Related to Clinical Evaluations of Inflammatory Activity but not with the Patient Developed Raid Questionnaire in RA Patients on Biologic Treatment |
| 002A13 (2013) |
G. Imametdinova ; E. Igolkina ; N. Chichasova ; E. Nasonov [Russie] ; S. Glukhova [Russie] | THU0156 The Evaluation of Joint Damage Progression in Patients with Rheumatoid Arthritis with Long-Term and Short-Term Remission |
| 002A14 (2013) |
G. Radunovic [Serbie] ; S. Prodanovic [Serbie] ; K. Simic Pasalic [Serbie] ; V. Milic [Serbie] ; N. Damjanov [Serbie] | THU0155 Sensitivity to Change of the Ultrasound Disease Activity Score |
| 002A15 (2013) |
J. Kremer [États-Unis] ; C. Zerbini [Brésil] ; E. B. Lee [Corée du Sud] ; D. Gruben [États-Unis] ; S. Krishnaswami [États-Unis] ; S. H. Zwillich [États-Unis] ; T. Koncz [États-Unis] ; J. Bradley [États-Unis] ; C. A. Mebus [États-Unis] | THU0143 Tofacitinib (CP-690,550), an oral janus kinase inhibitor: Analyses of efficacy endpoints by subgroups in a pooled phase 2 and 3 rheumatoid arthritis study population |
